• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Vital Images revs drop, loss grows

Article

Revenue at Vital Images dropped 19% in the third quarter compared to the year earlier period, but CEO Michael H. Carrel pointed to encouraging signs “in our marketplace.”

Vital Images revs drop, loss grows
Revenue at Vital Images dropped 19% in the third quarter compared to the year earlier period, but CEO Michael H. Carrel pointed to encouraging signs “in our marketplace.” Seeking to counter a fall in 3Q09 to $14.3 million from $17.7 million, the company recently launched its Vitrea Enterprise Suite, a centralized software product designed for managing volumetric data. Vital Images is setting its sights on the upcoming RSNA conference to promote sales. The company will need those sales, if it is to reverse the downward spiral of its bottom line, which sank to a third quarter net loss of $750,000 compared to a net loss of $243,000 in 3Q08.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.